FundedIQ
Biotechnology

ATCC: Funding, Investors & Team (Sep 2026)

ATCC global biological materials resource and standards organization whose mission focuses on the acquisition, authentication, production, preservation, development, and distribution of standard reference microorganisms, cell lines, and other materials. While maintaining traditional collection materials, ATCC develops high-quality products, standards, and services to support scientific research and breakthroughs that improve the health of global populations.

www.atcc.org/en.aspx LinkedIn Manassas, United States 501-1000 employees
Total raised
$5.5M
Rounds
1
Latest
Grant
Feb 2022

ATCC has raised $5.5M across 1 funding round on record, the most recent a Grant of $5.5M announced in Feb 2022.

That round is below the $8.0M median round size for Biotechnology companies tracked on FundedIQ over the last two years.

ATCC Company Profile and Key Stats

Total funding raised
$5.5M
across 1 round on record
Funding rounds on record
1
Latest funding round
Grant
$5.5M in Feb 2022
Employees
501-1000
reported band
Headquarters
Manassas, United States

Latest funding round on record: Feb 2022.

ATCC Funding Rounds

Date
Round
Amount
Grant
$5.5M

ATCC Founders and Leadership Team

Name
Role
Contact
Raymond Cypess
CEO
Locked

Contact details for the ATCC team: 1 of 1 has an email address on file.

Start 14-day free trial →

ATCC Funding Compared to Other Biotechnology Startups

Segment
Companies
Median round
4,183
$8.0M
29,878
$7.5M
1,065

ATCC's latest round of $5.5M is below the median round in Biotechnology. Medians cover the last 24 months of disclosed rounds.

Funded Startups Like ATCC in Biotechnology and Manassas

Companies Similar to ATCC

SeqWell’s is a biotechnology company that specializes in the fields of gene sequencing and laboratory…

Undisclosed round $960k

DermaSensor’s mission is to save lives and healthcare costs by providing easy access to effective skin cancer…

Series B $4.0M

Solstice Oncology is a clinical stage immuno-oncology company

Series A $225M

Encoded Therapeutics is a developer of precision gene therapies intended to provide treatment for a broad…

Series F $275M

BrainChild Bio is a biotechnology company in the clinical stage that specializes in pediatric brain tumors.…

Series A $116M

Superluminal Medicines is a biotech company that specializes in rapidly developing new drugs through a…

Series B $65.5M

Senticell's mission is to fully harness the unique immune and genetic functions of RBC to transform and treat…

Seed $7.0M

ImmunoPhotonics, Inc. develops immunotherapy-based treatments for cancer. ImmunoPhotonics, Inc. has a…

Series C $10.0M

EIT Pharma is a commercial-stage biotechnology company focuses on developing and commercializing…

Series A $35.0M

Halia Therapeutics is a biopharmaceutical company in the preclinical stage that is developing new treatments…

Convertible Note $3.5M

Noveome Biotherapeutics, Inc. is an advanced biopharmaceutical company that focuses on groundbreaking…

Convertible Note $6.8M

XiltriX North America is an information technology company that specializes in monitoring, predictive…

Undisclosed round $3.0M

ATCC Funding FAQs

What does ATCC do?

ATCC global biological materials resource and standards organization whose mission focuses on the acquisition, authentication, production, preservation, development, and distribution of standard reference microorganisms, cell lines, and other materials. While maintaining traditional collection materials, ATCC develops high-quality products, standards, and services to support scientific research and breakthroughs that improve the health of global populations.

How much funding has ATCC raised?

ATCC has raised $5.5M across 1 round on record. The most recent is a Grant of $5.5M announced in Feb 2022.

When did ATCC last raise funding?

ATCC's most recent funding round on record is a Grant of $5.5M, announced in Feb 2022.

Who is the CEO of ATCC?

Raymond Cypess is listed as CEO at ATCC.

Where is ATCC headquartered?

ATCC is based in Manassas, Virginia, United States.

How many employees does ATCC have?

ATCC is in the 501-1000 employee band.

How does ATCC's funding compare to other Biotechnology startups?

ATCC's latest round of $5.5M is below the $8.0M median round size for Biotechnology companies on FundedIQ across 4,183 tracked companies over the last two years.

About FundedIQ's ATCC Funding Data

FundedIQ tracks announced funding rounds and refreshes this profile every week. Round dates, stages and amounts are normalised to a single format, converted to US dollars, and de-duplicated: two records of the same round announced days apart are merged, and two genuinely different rounds are kept apart on the amounts they disclose. Amounts shown are the disclosed figures only — a round announced without a number is listed and excluded from the total rather than estimated.

Employee counts are reported bands, not exact headcounts. Founder and executive names carry the job title on record. Anything we do not hold for ATCC is left off this page rather than filled in.

14-day free trial · Cancel anytime

Know who just raised. Then know who to reach.

Every newly funded startup with its round, its investors and its founders: delivered weekly by email, or searchable in the app.

Alerts from $19/mo · Pro from $99/mo. Card required, nothing charged until day 15, and we email you 3 days before that.